RRC ID 52439
Author Sakagami H, Uesawa Y, Masuda Y, Tomomura M, Yokose S, Miyashiro T, Murai J, Takao K, Kanamoto T, Terakubo S, Kagaya H, Nakashima H, Sugita Y.
Title Quantitative Structure-Cytotoxicity Relationship of Newly Synthesized Piperic Acid Esters.
Journal Anticancer Res.
Abstract BACKGROUND/AIM:Eleven piperic acid esters were subjected to quantitative structure-activity relationship (QSAR) analysis based on their cytotoxicity and tumor-specificity, in order to find their new biological activities.
MATERIALS AND METHODS:Cytotoxicity against four human oral squamous cell carcinoma cell lines and three oral normal mesenchymal cells was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method. Tumor specificity (TS) was evaluated by the ratio of the mean 50% cytotoxic concentration (CC50) against normal cells to that against tumor cell lines. Potency-selectivity expression (PSE) value was calculated by dividing the TS value by CC50 against tumor cells. Apoptosis markers were detected by western blot analysis. Physicochemical, structural and quantum-chemical parameters were calculated based on the conformations optimized by force-field minimization.
RESULTS:One phenylmethyl ester and five phenylethyl esters showed relatively higher cytotoxicity and tumor specificity, that were significantly modified by introduction of hydroxyl and methoxy groups. On the other hand, phenylpropyl ester, phenylbutyl ester and decyl ester were essentially inactive. (2E,4E)-5-(3,4-methylenedioxyphenyl)-2,4-pentadienoic acid 2-(3,4-dihydroxyphenyl)ethyl ester [4] had the highest TS and PSE values. This compound also stimulated the cleavage of caspase-3, suggesting the induction of apoptosis. TS values were correlated with molecular size, ionization potential, molecular shape, ionization potential and electronegativity. None of the compounds had any anti-HIV activity.
CONCLUSION:Chemical modification of the lead compound may be a potential choice for designing a new type of anticancer drugs.
Volume 37(11)
Pages 6161-6168
Published 2017-11
DOI 10.21873/anticanres.12065
PII 37/11/6161
PMID 29061797
MeSH Anti-HIV Agents / pharmacology* Antineoplastic Agents / pharmacology Apoptosis / drug effects* Carcinoma, Squamous Cell / drug therapy* Carcinoma, Squamous Cell / pathology Cell Proliferation / drug effects Cells, Cultured Child Esters / pharmacology* Fatty Acids, Unsaturated / chemistry* Female HIV / drug effects* Humans Molecular Structure Mouth Neoplasms / drug therapy* Mouth Neoplasms / pathology Quantitative Structure-Activity Relationship
IF 1.865
Human and Animal Cells Ca9-22(RCB1976) HSC-2(RCB1945) HSC-4(RCB1902)